VanEck Associates’s National Health Investors NHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $714K | Buy |
10,184
+1,515
| +17% | +$106K | ﹤0.01% | 1110 |
|
|
2025
Q1 | $640K | Buy |
8,669
+710
| +9% | +$52.4K | ﹤0.01% | 1111 |
|
|
2024
Q4 | $552K | Buy |
7,959
+767
| +11% | +$53.2K | ﹤0.01% | 1120 |
|
|
2024
Q3 | $550K | Buy |
7,192
+788
| +12% | +$60.3K | ﹤0.01% | 1082 |
|
|
2024
Q2 | $434K | Buy |
6,404
+416
| +7% | +$28.2K | ﹤0.01% | 1105 |
|
|
2024
Q1 | $376K | Buy |
5,988
+137
| +2% | +$8.6K | ﹤0.01% | 1097 |
|
|
2023
Q4 | $327K | Buy |
5,851
+962
| +20% | +$53.8K | ﹤0.01% | 1099 |
|
|
2023
Q3 | $251K | Buy |
4,889
+202
| +4% | +$10.4K | ﹤0.01% | 1126 |
|
|
2023
Q2 | $246K | Buy |
4,687
+119
| +3% | +$6.25K | ﹤0.01% | 1148 |
|
|
2023
Q1 | $236K | Buy |
4,568
+237
| +5% | +$12.2K | ﹤0.01% | 1138 |
|
|
2022
Q4 | $226K | Buy |
4,331
+1,853
| +75% | +$96.7K | ﹤0.01% | 1060 |
|
|
2022
Q3 | $140K | Sell |
2,478
-1,525
| -38% | -$86.2K | ﹤0.01% | 1114 |
|
|
2022
Q2 | $243K | Buy |
4,003
+84
| +2% | +$5.1K | ﹤0.01% | 1035 |
|
|
2022
Q1 | $231K | Buy |
3,919
+514
| +15% | +$30.3K | ﹤0.01% | 1076 |
|
|
2021
Q4 | $196K | Buy |
3,405
+1,365
| +67% | +$78.6K | ﹤0.01% | 1114 |
|
|
2021
Q3 | $109K | Buy |
2,040
+275
| +16% | +$14.7K | ﹤0.01% | 1134 |
|
|
2021
Q2 | $118K | Sell |
1,765
-46
| -3% | -$3.08K | ﹤0.01% | 1072 |
|
|
2021
Q1 | $131K | Buy |
1,811
+82
| +5% | +$5.93K | ﹤0.01% | 983 |
|
|
2020
Q4 | $120K | Buy |
1,729
+431
| +33% | +$29.9K | ﹤0.01% | 891 |
|
|
2020
Q3 | $78K | Buy |
1,298
+247
| +24% | +$14.8K | ﹤0.01% | 905 |
|
|
2020
Q2 | $64K | Buy |
1,051
+530
| +102% | +$32.3K | ﹤0.01% | 891 |
|
|
2020
Q1 | $26K | Buy |
521
+271
| +108% | +$13.5K | ﹤0.01% | 909 |
|
|
2019
Q4 | $20K | Buy |
+250
| New | +$20K | ﹤0.01% | 918 |
|